Literature DB >> 23609134

[Concurrent radiochemotherapy with 5-FU/mitomycin remains standard treatment for anal carcinoma. Long-term results of the phase III RTOG 98-11 trial].

C Nieder1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23609134     DOI： 10.1007/s00066-013-0335-0

Source DB:  PubMed          Journal:  Strahlenther Onkol        ISSN： 0179-7158            Impact factor:   3.621


× No keyword cloud information.
  3 in total

1.  Radiotherapy with or without chemotherapy in the treatment of anal cancer: 20-year experience from a single institute.

Authors:  K Fakhrian; T Sauer; S Klemm; C Bayer; B Haller; M Molls; H Geinitz
Journal:  Strahlenther Onkol       Date:  2012-11-15       Impact factor: 3.621

2.  Induction chemotherapy and dose intensification of the radiation boost in locally advanced anal canal carcinoma: final analysis of the randomized UNICANCER ACCORD 03 trial.

Authors:  Didier Peiffert; Laetitia Tournier-Rangeard; Jean-Pierre Gérard; Claire Lemanski; Eric François; Marc Giovannini; Frédérique Cvitkovic; Xavier Mirabel; Olivier Bouché; Elisabeth Luporsi; Thierry Conroy; Christine Montoto-Grillot; Françoise Mornex; Antoine Lusinchi; Jean-Michel Hannoun-Lévi; Jean-François Seitz; Antoine Adenis; Christophe Hennequin; Bernard Denis; Michel Ducreux
Journal:  J Clin Oncol       Date:  2012-04-23       Impact factor: 44.544

3.  Long-term update of US GI intergroup RTOG 98-11 phase III trial for anal carcinoma: survival, relapse, and colostomy failure with concurrent chemoradiation involving fluorouracil/mitomycin versus fluorouracil/cisplatin.

Authors:  Leonard L Gunderson; Kathryn A Winter; Jaffer A Ajani; John E Pedersen; Jennifer Moughan; Al B Benson; Charles R Thomas; Robert J Mayer; Michael G Haddock; Tyvin A Rich; Christopher G Willett
Journal:  J Clin Oncol       Date:  2012-11-13       Impact factor: 44.544
  3 in total
  1 in total

1.  Role of brachytherapy in the treatment of cancers of the anal canal. Long-term follow-up and multivariate analysis of a large monocentric retrospective series.

Authors:  Laëtitia Lestrade; Berardino De Bari; Pascal Pommier; Xavier Montbarbon; Emilie Lavergne; Jean-Michel Ardiet; Christian Carrie
Journal:  Strahlenther Onkol       Date:  2014-03-11       Impact factor: 3.621
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.